ArticleTropical animal health and production2022
Fast growing broiler production from genetically different pure lines in Turkey. 1. Parental traits: growth, feed intake, reproduction, and hatching traits.
Article in Tropical animal health and production, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of the present study was to reveal the trends in age-related growth, feed intake, reproduction, and hatchability traits in 5 pure line (PL) breeders (3 dam [A1: slow-feathering, A2: fast-feathering, A3: slow-feathering] and 2 sire [B1: fast-feathering, B2: fast-feathering]) and their reciprocal two-way cross parent stock (PS) breeders (6 female [A1♂ × A2♀; A1♂ × A3♀; A2♂ × A1♀; A2♂ × A3♀; A3♂ × A1♀; A3♂ × A2♀] and 2 male [B1♂ × B2♀; B2♂ × B1♀]) and to identify heterotic effects in two-way cross PS combinations showing superiority over PL breeders. In the rearing period, 60 females and 15 males in the each PL group, 120 females in each female PS and 120 males in each male PS breeders, and 40 females and 5 males were used in each PL and PS genotype in the laying period. Body weight (BW), average daily feed intake (ADFI), reproductive traits (age at first egg [AFE], age at sexual maturity [ASM], egg number, weekly and total %Lay, egg weight, egg mass), hatching traits (fertility, hatchability of fertile [HOF] and set [HOS] and embryonic mortality), and heterosis (%) values for some traits were assesed. Both males and females of PLs and PSs had different BW at 4 and 8 weeks of age (P < 0.01), but had similar BW from 12 to 24 weeks of age. The A2, B1, and B2 hens had a higher BW (nearly 4000 g) than the others at 31 weeks of age (P < 0.01), and B2 hens showed a BW of more than 5000 g at 64 weeks (P < 0.001). Weekly ADFI per female in rearing, laying, and overall period was not different between groups. The A1 (179 days), A3 (183 days), two-way cross (from 175.5 to 185.5 days) hens started laying at a similar age and earlier than B1 (184 days), A2 (192 days), and B2 (194 days) hens. From AFE to 64 weeks, %Lay was the highest in the A1 line (69.7%), lowest in the B1 (45.3%) and B2 (48.8%) line, and between 56.9 and 64.8% in PS breeder hens. The PS eggs tended to have higher fertility, HOF, and HOS, and less embryonic mortality compared to PL eggs. Negative and low heterosis for AFE was observed in PS eggs, while positive heterosis for fertility, HOF, and HOS was generally observed in four-way hybrid eggs. The highest heterosis for the 64-week cumulative egg number was observed in A3 × A2 hens. Our study results show that mating of B1 × B2 males with A3 × A2 females seems more favorable in terms of higher egg or chick production. However, more knowledge is also needed for the overall efficiency of each PS, including the final performance of its hybrids.
Indexed as
Identifiers
36161536What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.